JRC Publications Repository

JRC Publications Repository >

Browsing by Author NIKULA T.

Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 8 of 8
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2000Alpha-Emitting Bismuth Cyclohexybenzyl DTPA Constructs of Recombinant Humanized Anti-CD33 Antibodies: Pharmacokinetics, Bioactivity, Toxicity and Chemistry.NIKULA T.; MC DEVITT M.r.; WU Ch.; KOZAK R.w.; GARMESTANI K.; BRECHBIEL M.w.; CURCIO M.j.; PIPPIN C.g.; TIFFANI-JONES L.; GEERLINGS, SR. M.w., et alArticles in Journals
2000Binding of a Bi-213 Labeled Monoclonal Antibody Targeting a Tumor Specific Mutant E-Cadherin in Different Tumor Models.ADAM C.; SCHUHMACHER C.; BECKER K.; HANDSCHUH G.; NIKULA T.; APOSTOLIDIS Christos; FISCHER K.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2001Cancer Treatment Using Bi-213 and Ac-225 in Radioimmunotherapy.APOSTOLIDIS Christos; CARLOS-MARQUEZ R.; JANSSENS Willem; MOLINET Roger; NIKULA T.; QUADI AliArticles in Journals
2003Comparison of the Radiotoxicity of two Alpha-Particle-Emitting Immunoconjugates, Terbium-149 and Bismut-213, Directed against a Tumor-Specific, Exon 9 Deleted (d99) E-Cadherin Adhesion Protein.MIEDERER M.; SEIDL C.; BEYER G.; CHARLTON D.e.; VRANJES-DURIC S.; COMOR J.j.; HUBER Roswitha; NIKULA T.; APOSTOLIDIS Christos; SCHUMACHER C., et alArticles in Journals
2000Cytotoxicity of the alpha Emitter 213-Bi Coupled to a Specific Antobody.MIEDERER M.; NIKULA T.; BRANDES K.; HANDSCHUH G.; ADAM C.; SCHUMACHER C.; APOSTOLIDIS Christos; BRECHBIEL M.; SCHMID E.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2001Lysine Protection against Bismuth Accumulation in the Kidneys when Using 213-Bi-DTPA-MAB.NIKULA T.; APOSTOLIDIS Christos; MOLINET Roger; CARLOS-MARQUEZ R.; BRANDES K.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2001Production of Carrier Free Actinium-225/Bismuth-212 from Thorium-229 for alpha-Immunitherapy.APOSTOLIDIS Christos; BETTI Maria; CARLOS-MARQUEZ R.; JANSSENS Willem; MOLINET Roger; NIKULA T.; QUADI AliContributions to Conferences
2000Tumor Binding and Therapeutic Efficacy of 213-Bi Labeled Mutation Specific Monoclonal Antobody in a Human Intraperitoneal Gastric Cancer Model.SENEKOWITSCH-SCHMIDTKE R.; FISCHER K.; SCHUMACHER C.; BECKER I.; BECKER K.; APOSTOLIDIS Christos; NIKULA T.; SCHWAIGER M.Contributions to Conferences
Showing results 1 to 8 of 8

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top